Synairgen Yönetim
Yönetim kriter kontrolleri 4/4
Synairgen's CEO is Richard Marsden, appointed in Sep 2009, has a tenure of 15.17 years. total yearly compensation is £328.00K, comprised of 94.5% salary and 5.5% bonuses, including company stock and options. directly owns 0.49% of the company’s shares, worth £47.45K. The average tenure of the management team and the board of directors is 3.8 years and 8.7 years respectively.
Anahtar bilgiler
Richard Marsden
İcra Kurulu Başkanı
UK£328.0k
Toplam tazminat
CEO maaş yüzdesi | 94.5% |
CEO görev süresi | 15.2yrs |
CEO sahipliği | 0.5% |
Yönetim ortalama görev süresi | 3.8yrs |
Yönetim Kurulu ortalama görev süresi | 8.7yrs |
Son yönetim güncellemeleri
Recent updates
Here's Why We're Not Too Worried About Synairgen's (LON:SNG) Cash Burn Situation
Dec 09Here's Why We're Watching Synairgen's (LON:SNG) Cash Burn Situation
Aug 24Is Synairgen (LON:SNG) In A Good Position To Invest In Growth?
Apr 29Companies Like Synairgen (LON:SNG) Could Be Quite Risky
Dec 27We're A Little Worried About Synairgen's (LON:SNG) Cash Burn Rate
Sep 13Companies Like Synairgen (LON:SNG) Could Be Quite Risky
May 31Here's Why We're Not Too Worried About Synairgen's (LON:SNG) Cash Burn Situation
Feb 06We're Hopeful That Synairgen (LON:SNG) Will Use Its Cash Wisely
Oct 21We're Hopeful That Synairgen (LON:SNG) Will Use Its Cash Wisely
Mar 29How Much Of Synairgen plc (LON:SNG) Do Institutions Own?
Dec 14CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -UK£7m |
Mar 31 2024 | n/a | n/a | -UK£8m |
Dec 31 2023 | UK£328k | UK£310k | -UK£8m |
Sep 30 2023 | n/a | n/a | -UK£9m |
Jun 30 2023 | n/a | n/a | -UK£10m |
Mar 31 2023 | n/a | n/a | -UK£14m |
Dec 31 2022 | UK£328k | UK£310k | -UK£18m |
Sep 30 2022 | n/a | n/a | -UK£23m |
Jun 30 2022 | n/a | n/a | -UK£28m |
Mar 31 2022 | n/a | n/a | -UK£38m |
Dec 31 2021 | UK£1m | UK£256k | -UK£49m |
Sep 30 2021 | n/a | n/a | -UK£46m |
Jun 30 2021 | n/a | n/a | -UK£43m |
Mar 31 2021 | n/a | n/a | -UK£28m |
Dec 31 2020 | UK£415k | UK£194k | -UK£14m |
Sep 30 2020 | n/a | n/a | -UK£10m |
Jun 30 2020 | n/a | n/a | -UK£6m |
Mar 31 2020 | n/a | n/a | -UK£5m |
Dec 31 2019 | UK£289k | UK£190k | -UK£4m |
Sep 30 2019 | n/a | n/a | -UK£4m |
Jun 30 2019 | n/a | n/a | -UK£4m |
Mar 31 2019 | n/a | n/a | -UK£3m |
Dec 31 2018 | UK£205k | UK£186k | -UK£3m |
Sep 30 2018 | n/a | n/a | -UK£898k |
Jun 30 2018 | n/a | n/a | UK£2m |
Mar 31 2018 | n/a | n/a | UK£2m |
Dec 31 2017 | UK£336k | UK£182k | UK£2m |
Tazminat ve Piyasa: Richard's total compensation ($USD423.80K) is about average for companies of similar size in the UK market ($USD369.83K).
Tazminat ve Kazançlar: Richard's compensation has been consistent with company performance over the past year.
CEO
Richard Marsden (57 yo)
15.2yrs
Görev süresi
UK£328,000
Tazminat
Mr. Richard Marsden has been Chief Executive Officer of Synairgen Research Ltd since September 2009. Mr. Marsden has been Managing Director and Executive Director at Synairgen since June 2004 has been its...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
CEO, MD & Executive Director | 15.2yrs | UK£328.00k | 0.49% £ 47.4k | |
Co-Founder | no data | UK£40.00k | 0.45% £ 43.5k | |
CFO & Executive Director | less than a year | UK£197.41k | Veri yok | |
Chairman of Scientific Advisory Board | 15.2yrs | UK£241.00k | 0.21% £ 20.2k | |
Co-Founder & Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Co-Founder & Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Chief Regulatory Officer | 3.1yrs | Veri yok | Veri yok | |
Senior VP & Head of Clinical Operations | 12.9yrs | Veri yok | Veri yok | |
Senior VP and Head of CMC & Quality | 3.2yrs | Veri yok | Veri yok | |
Head of Laboratory | 5.6yrs | Veri yok | Veri yok | |
Chief Medical Officer | 1.1yrs | Veri yok | Veri yok | |
Company Secretary | 3.8yrs | Veri yok | Veri yok |
3.8yrs
Ortalama Görev Süresi
56yo
Ortalama Yaş
Deneyimli Yönetim: SNG's management team is considered experienced (3.8 years average tenure).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
CEO, MD & Executive Director | 20.4yrs | UK£328.00k | 0.49% £ 47.4k | |
Co-Founder | 21.4yrs | UK£40.00k | 0.45% £ 43.5k | |
CFO & Executive Director | less than a year | UK£197.41k | Veri yok | |
Chairman of Scientific Advisory Board | 15.2yrs | UK£241.00k | 0.21% £ 20.2k | |
Co-Founder & Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Co-Founder & Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Chairman | less than a year | Veri yok | Veri yok | |
Non-Executive Director & Member of Scientific Advisory Board | 18.6yrs | UK£40.00k | 0.16% £ 15.8k | |
Member of Scientific Advisory Board & Independent Non-Executive Director | 2.2yrs | UK£45.00k | Veri yok | |
Independent Non-Executive Director | 1.9yrs | UK£45.00k | Veri yok |
8.7yrs
Ortalama Görev Süresi
57yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: SNG's board of directors are considered experienced (8.7 years average tenure).